WIN-Partners Co., Ltd. Stock

Equities

3183

JP3154390003

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange 02:00:00 2024-04-16 am EDT 5-day change 1st Jan Change
1,181 JPY -1.50% Intraday chart for WIN-Partners Co., Ltd. -2.32% -1.25%
Sales 2022 66.39B 429M Sales 2023 70.85B 458M Capitalization 28.87B 187M
Net income 2022 1.83B 11.84M Net income 2023 2.05B 13.24M EV / Sales 2022 0.19 x
Net cash position 2022 15.57B 101M Net cash position 2023 16.77B 108M EV / Sales 2023 0.17 x
P/E ratio 2022
15.6 x
P/E ratio 2023
14.1 x
Employees 609
Yield 2022
3.5%
Yield 2023
3.54%
Free-Float 52.95%
More Fundamentals * Assessed data
Dynamic Chart
Win-Partners Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year Ending March 31, 2024 CI
WIN-Partners Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
WIN-Partners Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year Ending March 31, 2024 CI
WIN-Partners Co., Ltd. intends to acquire Trytech Corporation from MEDIX JAPAN,Inc. CI
WIN-Partners Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023 CI
WIN-Partners Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023 CI
Blisspack Co.,Ltd and Win Partners Co., Ltd cancelled the acquisition of 12.74% stake in FN REPUBLIC Co., Ltd from FN Cosmedics Co., Ltd.. CI
Blisspack Co.,Ltd and Win Partners Co., Ltd agreed to acquire 12.74% stake in FN REPUBLIC Co., Ltd from FN Cosmedics Co., Ltd. for KRW 7 billion. CI
WIN-Partners Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Fiscal Year Ending March 31, 2023 CI
WIN-Partners Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Year Ending March 31, 2023 CI
Tranche Update on WIN-Partners Co., Ltd.'s Equity Buyback Plan announced on February 10, 2022. CI
WIN-Partners Co., Ltd.'s Equity Buyback announced on February 10, 2022, has expired with 288,500 shares, representing 1% for ¥298.08 million. CI
WIN-Partners Co., Ltd. announces an Equity Buyback for 300,000 shares, representing 1.04% for ¥300 million. CI
WIN-Partners Co., Ltd. authorizes a Buyback Plan. CI
WIN-Partners Co., Ltd.(TSE:3183) dropped from S&P Global BMI Index CI
More news
1 day-1.50%
1 week-2.32%
Current month-3.43%
1 month-6.05%
3 months-2.72%
6 months+10.58%
Current year-1.25%
More quotes
1 week
1 175.00
Extreme 1175
1 223.00
1 month
1 174.00
Extreme 1174
1 279.00
Current year
1 174.00
Extreme 1174
1 344.00
1 year
980.00
Extreme 980
1 344.00
3 years
914.00
Extreme 914
1 344.00
5 years
782.00
Extreme 782
1 548.00
10 years
497.00
Extreme 497
1 884.00
More quotes
Managers TitleAgeSince
President 63 13-03-31
Chief Administrative Officer 64 15-10-31
Director/Board Member 48 13-03-31
Members of the board TitleAgeSince
President 63 13-03-31
Director/Board Member 64 13-03-31
Chief Administrative Officer 64 15-10-31
More insiders
Date Price Change Volume
24-04-16 1,181 -1.50% 32 100
24-04-15 1,199 -0.33% 30,000
24-04-12 1,203 -1.31% 27,500
24-04-11 1,219 +0.99% 39,100
24-04-10 1,207 -0.17% 12,200

Delayed Quote Japan Exchange, April 16, 2024 at 02:00 am EDT

More quotes
WIN-Partners Co., Ltd. is a Japan-based company primarily engaged in the medical equipment supply business through its subsidiaries. The Company is mainly in the provision of medical device, such as catheters used in ischemic heart disease, pacemakers used in cardiac rhythm management area, artificial blood vessels used for cardiovascular surgery area, embolization coil used in peripheral vascular disease and brain surgery, as well as the provision of large -scale medical equipment, such as computed tomography equipment (CT) used in the radiology department and the operating room.
Calendar
More about the company